Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 15/03/2010 The photo shows six wells containing four brain slices each.<br />

    Borna disease virus and cell death in the brain

    A research group led by Prof. Dr. Bernd Heimrich at the University of Freiburg is investigating how the Borna disease virus can alter characteristic neuronal circuits and destroy the hippocampal nerve cells. The scientists have developed an extremely practical petri dish test system. Their results show which cell types sustain the most damage following infection and also give indications as to how apoptosis cell death can be prevented.

    https://www.gesundheitsindustrie-bw.de/en/article/news/borna-disease-virus-and-cell-death-in-the-brain
  • Article - 15/03/2010 10460_de.jpg

    Innovative navigation system enables gene shuttles to reach their destination

    If everything goes to plan the Department of Gene Therapy at the University of Ulm will soon lose a work group to industry. Florian Kreppels team plans to turn a particular technology into hard cash using a method that can do something other gene shuttles are unable to do namely transport their freight to a specific destination.

    https://www.gesundheitsindustrie-bw.de/en/article/news/innovative-navigation-system-enables-gene-shuttles-to-reach-their-destination
  • Article - 15/03/2010 Human papillomaviruses - electron microscope photo

    The first active immunisations against cancer

    The first anti-cancer vaccines were developed to prevent women from becoming infected with papillomaviruses and to protect them against cervical cancer. The development of vaccines can be traced back to the work of Nobel Laureate Harald zur Hausen and his colleagues at the German Cancer Research Centre in Heidelberg. But more development is required in the field of anti-cancer vaccines and this is why researchers worldwide are working on vaccines…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-first-active-immunisations-against-cancer
  • Press release - 23/12/2009 Portrait of Prof. Dr. Frank Kirchhoff

    The spread of HIV: optimal adaptation to the human host

    A new study led by the virologist and Leibniz Award winner Frank Kirchhoff from Ulm might be about to provide an explanation as to why only one of several independent transmissions of simian immunodeficiency viruses (SIV) from chimpanzees to humans led to the global AIDS pandemic. The researchers now hope that these new findings will contribute to the search for new strategies to prevent the further spread of AIDS viruses.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-spread-of-hiv-optimal-adaptation-to-the-human-host
  • Press release - 08/12/2009 10296_de.jpg

    Vaccination of honeybees against the Varroa mite is possible

    For the first time ever, honeybees were orally ‚vaccinated’ with a genetically engineered product that was later detected in the bloodsucking Varroa mite. This product is a DNA-plasmid that is normally used for man, horses, swine and also for fish. The inventor of this innovative DNA-vaccination system for bees is Matthias Giese, PhD, who launches his own Institute for Molecular Vaccines (IMV) in Heidelberg/Germany starting in 2010.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/vaccination-of-honeybees-against-the-varroa-mite-is-possible
  • Press release - 04/12/2009 Human papillomaviruses - electron microscope photo

    Papillomavirus oncogene silences innate immune response

    Human papillomavirus type 16, the most frequent cause of cervical cancer, is able to silence a signalling molecule in the host cells that is needed for immune responses to occur. If the body is unable to defend itself against intruders, the viruses can successfully invade the cells of the cervical mucosa. Researchers from the German Cancer Research Centre have discovered that the viral E6 oncogene is responsible for this mechanism.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/papillomavirus-oncogene-silences-innate-immune-response
  • Press release - 17/11/2009 The photo shows the team from Freiburg at the prize award ceremony at the Massachusetts Institute of Technology (MIT)

    iGEM team Freiburg: a standing order for gold medals

    The Bioware team from Freiburg, an important part of the bioss cluster of excellence, has once again achieved resounding success: one gold medal and two special prizes at the iGEM competition (international Genetically Engineered Machine), the largest event for up-and-coming scientists focusing on synthetic biology. It was the turn of the research group heads, junior professor Dr. Kristian Müller and Dr. Katja Arndt, to participate in the…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/igem-team-freiburg-a-standing-order-for-gold-medals
  • Press release - 16/11/2009 10118_de.jpg

    No-Entry Zones for AIDS Virus

    The AIDS virus (HIV) inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/no-entry-zones-for-aids-virus
  • Press release - 18/09/2009 09660_de.jpg

    How HIV disables immune cells

    In order to be able to ward off disease pathogens, immune cells must be mobile and able to establish contact with each other. Professor Dr. Oliver Fackler’s group of researchers in the Department of Virology of the Institute of Hygiene at the University of Heidelberg has discovered a mechanism in an animal model revealing how HI viruses cripple immune cells: The mobility of cells is inhibited by the protein Nef. The study, which was published in…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-hiv-disables-immune-cells
  • Press release - 31/07/2009

    Liver research to receive one million euro in funding

    The INTERREG programme of the European Union will provide funding for a liver disease research project conducted by the Department of Internal Medicine II at the Freiburg University Medical Centre. The “Hepato-Regio-Net” will receive a total of one million euro in funding for a period of three years. Prof. Dr. Robert Thimme, executive senior physician in the Department of Medicine, will serve as the project’s spokesperson and Dr. Richard Fischer,…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/liver-research-to-receive-one-million-euro-in-funding
  • Article - 30/07/2009 09261_de.jpg

    Keeping as many valuable attachments as possible

    The goal of many projects focusing on the purification of recombinant proteins is to rapidly and effectively remove substances and side products that would compromise the quality and quantity of biopharmaceutical compounds. A consortium of industrial and scientific partners is currently focusing on a different step in the biopharmaceutical production process: the goal is to keep as many as possible of the drugs’ ‘attachments’. The project focuses…

    https://www.gesundheitsindustrie-bw.de/en/article/news/keeping-as-many-valuable-attachments-as-possible
  • Press release - 30/07/2009

    Why do hepatitis virus infections become chronic?

    The German Research Foundation (DFG) has approved funding for a new research project at the Universities of Freiburg and Heidelberg. The researchers are working on improving our understanding of the mechanisms that lead to chronic virus infections: how do hepatitis viruses manage to evade immunological defence reactions and survive in the organism without damaging the organism?

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/why-do-hepatitis-virus-infections-become-chronic
  • Article - 09/07/2009 An RNA tumor virus budding from the surface of a mouse sarcoma cell and a virus already released from the cell. Electron micrograph (Source: Cell and Tumor Biology, German Cancer research Center, Heidelberg)

    Four Nobel Prizes for a chicken virus

    The Rous sarcoma virus (RSV) was the starting point of the discovery that cancer can be brought on by infections. The enzyme “reverse transcriptase”, which led to a rethinking and technological revolution in the field of molecular biology, was discovered in this retrovirus along with oncogenes that led to a completely new concept of cancer development in molecular genetics and eventually to the development of a new generation of cancer…

    https://www.gesundheitsindustrie-bw.de/en/article/news/four-nobel-prizes-for-a-chicken-virus
  • Article - 02/07/2009 HCMV has been detected in a renal artery organ model. The electron microscope image clearly shows the spiky spherical pathogen.

    A virus that hides while it waits for an opportunity to replicate

    Thomas Mertens, Medical Director of the Institute of Virology in Ulm, has a strong scientific and clinical interest in the human cytomegalovirus (HCMV), a big virus with a big impact which, despite its size, is overshadowed by known viruses such as the HI virus that is the object of research for Mertens’ colleagues. HCMV research is a challenging area where quick successes are rare.

    https://www.gesundheitsindustrie-bw.de/en/article/news/a-virus-that-hides-while-it-waits-for-an-opportunity-to-replicate
  • Press release - 29/06/2009

    New electron microscopy images reveal the assembly of HIV

    Scientists at the European Molecular Biology Laboratory (EMBL) and the University Clinic Heidelberg, Germany, have produced a three-dimensional reconstruction of HIV (Human Immunodeficiency Virus), which shows the structure of the immature form of the virus at unprecedented detail. Immature HIV is a precursor of the infectious virus, which can cause AIDS. The study, published in the 22-26 June online edition of PNAS, describes how the protein…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-electron-microscopy-images-reveal-the-assembly-of-hiv
  • Dossier - 25/06/2009 The replication fork, which is created through the action of the enzyme helicase, and all the enzymes that are important for DNA replication. The schematic depicts the mechanism of DNA replication.

    DNA and RNA replication

    The replication of the genome is essential for the continuity of life. The molecular mechanism is very similar in all groups of organisms. Although the basics of replication are already well understood, researchers are still focusing on questions relating to DNA replication. These questions not only deal with the understanding of a basic biological process, but also with related medical aspects.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/dna-and-rna-replication
  • Article - 23/06/2009 The reverse transcriptase (RT) is part of a protein complex known as P protein. This also involves the terminal protein (TP) and RNase H (RH) domains. Protein P forms a complex with pre-genomic RNA (pgRNA) by binding to the epsilon loop (ε). The terminal protein then creates the DNA primer (red).

    Hepatitis B and the Münchhausen enzyme

    Virologists in Prof. Dr. Michael Nassals group at the University Medical Centre in Freiburg are investigating the molecular mechanisms used by the hepatitis B virus to reproduce. The researchers work might in future be able to help the three to four hundred million people worldwide who suffer from chronic hepatitis B infections.

    https://www.gesundheitsindustrie-bw.de/en/article/news/hepatitis-b-and-the-muenchhausen-enzyme
  • Press release - 10/06/2009 08834_de.jpg

    New tests for and new data about the new influenza type

    In Germany, test methods that enable the identification of an infection caused by the new influenza A/H1N1 virus, even after the symptoms have subsided or disappeared completely, have become available for the first time. The National Influenza Reference Centre (NRZ) at the Robert Koch Institute has developed two serological tests based on the detection of antibodies in the blood serum. The antibodies are produced about 2 weeks after onset of…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-tests-for-and-new-data-about-the-new-influenza-type
  • Press release - 30/04/2009 08506_de.jpg

    In the tubular system of human cells

    Scientists from the Hygiene Institute at the Heidelberg University Hospital have succeeded for the first time ever in showing the three-dimensional architecture of the dengue virus replication and assembly sites in human cells. Their paper was recently published in the renowned journal “Cell Host & Microbes”.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/in-the-tubular-system-of-human-cells
  • Press release - 08/01/2009 Two pictures: The picture on the left shows a fluorescence-labelled antibody; yellow liquid is withdrawn with a thin tube from a vial shown below the antibody. The picture on the left shows the thin tube in a black square. Flash-shaped arrows (red, green) (fluorescence)point towards the right of the black square.<br />

    ILM – Optical analytics

    In collaboration with the company Labor Dr. Merk & Kollegen GmbH and the Institute of Virology at the University of Ulm, the ILM is developing an innovative detection system for the early diagnosis of influenza virus infections in pharyngeal secretions.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ilm-optical-analytics
  • Article - 05/12/2008

    Secret biological recipes for a long life

    Staying healthy as you get older that is probably what many people would wish for. As part of the European research network LifeSpan 130 scientists are now looking into how to make this wish come true. Prof. Dr. Graham Pawelec from the University Hospital of Tübingen UKT is one of the 130 scientists and his principal focus is immunological ageing processes.

    https://www.gesundheitsindustrie-bw.de/en/article/news/secret-biological-recipes-for-a-long-life
  • Press release - 04/12/2008 Portrait of Prof. Dr. Frank Kirchhoff

    Leibniz Awards for two Ulm University professors

    Prof. Dr. Frank Kirchhoff Institute of Virology and Prof. Dr. Karl Lenhard Rudolph Institute of Molecular Medicine from the University of Ulm have received two of the German Research Foundations eleven Gottfried Wilhelm Leibniz Programme awards.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/leibniz-awards-for-two-ulm-university-professors
  • Article - 01/11/2008

    Toxic bile damages the liver

    Researchers at Heidelberg University Hospital discover a new genetic disease in which a mutation in a transport protein gene makes bile toxic and triggers severe cirrhosis of the liver. The research has been published in the journal Hepatology.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/toxic-bile-damages-the-liver
  • Press release - 06/10/2008

    Harald zur Hausen wins Nobel Prize in Medicine

    Harald zur Hausen the long-time chairman and scientific director of the German Cancer Research Centre DKFZ a member of the Helmholtz Society discovered that human papillomaviruses HPV lead to cervical cancer. His discovery led to the development of a vaccine for cervical cancer which is the third most frequent type of cancer in women.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/harald-zur-hausen-wins-nobel-prize-in-medicine
  • Article - 05/10/2008

    Award for AIDS researcher from Ulm

    The Dr. Ernst Wiethoff Award 2008 for innovative clinical research worth 25000 euros was presented to Jan Münch from the Institute of Virology at the University Hospital of Ulm. Münch discovered a new protein that blocks the HI virus.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/award-for-aids-researcher-from-ulm

Page 7 / 8

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2022
Website address: https://www.gesundheitsindustrie-bw.de/en/search